Immune Checkpoint Inhibitors in the Treatment of Selected Tumor Types : A New Direction
In-Person Event
Apr 23, 2016
Houston, Texas, USA
OVERVIEW
Immune Checkpoint Inhibitors in the Treatment of Selected Tumor Types : A New Direction is organized by CancerNet, LLC and Jointly sponsored by The A. Webb Roberts Center for CME of Baylor Health Care System, CancerNet and American Health Resource, Inc. the conference would be held on Apr 23, 2016 at Houston Marriott at the Texas Medical Center, Houston, Texas, United States of America.
The targeted audience for this medical meeting basically for hematologists/oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in immunotherapy options for selected tumor types. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity. This CME conference is approved of 6.0 AMA PRA Category 1 Credit(s)™. The Registration fee partially covers continental breakfast, lunch and syllabus book
This year the conference brings to you didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. This symposium is intended to improve care of patients with immunotherapeutic options for selected tumor types by accelerating adoption of new evidence-based practice change.
The targeted audience for this medical meeting basically for hematologists/oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in immunotherapy options for selected tumor types. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity. This CME conference is approved of 6.0 AMA PRA Category 1 Credit(s)™. The Registration fee partially covers continental breakfast, lunch and syllabus book
This year the conference brings to you didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. This symposium is intended to improve care of patients with immunotherapeutic options for selected tumor types by accelerating adoption of new evidence-based practice change.
KEY DATES
23 Apr, 2016
Event Start Date
23 Apr, 2016
Event End Date
SUGGESTED HOTELS
CONFERENCE VENUE
Houston Marriott At The Texas Medical CenterQuick Links